Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate

European Journal of Neurology

Volumn 14, Issue 3, 2007, Pages 309-314

  Raghavendra, S ^a   Nair, M D ^a   Chemmanam, T ^a   Krishnamoorthy, T ^a   Radhakrishnan, V V ^a   Kuruvilla, A ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Disseminated necrotizing leukoencephalopathy; Magnetic resonance imaging; Methotrexate encephalopathy; Methotrexate toxicity; Posterior leucoencephalopathy

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HYDROXYCHLOROQUINE; MELPHALAN; METHOTREXATE; PHENYTOIN; VINCRISTINE;

ADULT; ANAMNESIS; ARTICLE; CAPILLARY; CASE REPORT; CELL AGGREGATION; CELL INFILTRATION; DEMYELINATING DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FIBRIN FORMATION; HUMAN; HUMAN TISSUE; LEUKOENCEPHALOPATHY; LONG TERM CARE; LOW DRUG DOSE; LYMPHOCYTE; MACROPHAGE; MONOCYTE; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STEREOTAXIC SURGERY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRAIN DAMAGE, CHRONIC; BRAIN EDEMA; CEREBRAL ARTERIES; COGNITION DISORDERS; DEXAMETHASONE; DIFFUSION MAGNETIC RESONANCE IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLIOSIS; GLUCOCORTICOIDS; HUMANS; METHOTREXATE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEURODEGENERATIVE DISEASES; TELENCEPHALON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33847703295     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01659.x     Document Type: Article

References (24)

1. Henderson RD, Rajah T, Nicol AJ, Read SJ. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 2003; 60: 326-328.
2. Ilhan I, Cila A, Buyukpamukcu M, Akyuz C, Kutluk T, Berberoglu S. Methotrexate-induced leukoencephalopathy. A case report. Turkish Journal of Pediatrics 1995; 37: 275-278.
3. Mahoney DH Jr, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy - a Pediatric Oncology Group study. Journal of Clinical Oncology 1998; 16: 1712-1722.
4. Oka M, Terae S, Kobayashi R, et al. MRI in methotrexate-related leukoencephalopathy: disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy. Neuroradiology 2003; 45: 493-497.
5. Boogerd W, Sande JJ, Moffie D. Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate. Journal of Neurology, Neurosurgery and Psychiatry 1988; 51: 1277-1283.
6. Allen JC, Rosen G, Mehta BM, Horten B. Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. Cancer Treatment Reports 1980; 64: 1261-1273.
7. Lovblad K, Kelkar P, Ozdoba C, Ramelli G, Remonda L, Schroth G. Pure methotrexate encephalopathy presenting with seizures: CT and MRI features. Pediatric Radiology 1998; 28: 86-91.
8. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. New England Journal of Medicine 1996; 334: 494-500.
9. Poskitt KJ, Steinbok P, Flodmark O. Methotrexate leukoencephalopathy mimicking cerebral abscess on CT brain scan. Childs Nervous System 1988; 4: 119-121.
10. Schwartz RB, Jones KM, Kalina P, et al. Pathogenesis hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR. American Journal of Roentgenology 1992; 159: 379-383.
11. Ohmoto Y, Kajiwara K, Kato S, Nisizaki T, Ito H, Tamura S. Atypical MRI findings in treatment related leukoencephalopathy: case report. Neuroradiology 1996; 38: 128-133.
12. Kuker W, Bader P, Herrlinger U, Heckl S, Nagele T. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI. Journal of Neuro-Oncology 2005; 73: 47-49.
13. Haykin ME, Gorman M, van Hoff J, Fulbright RK, Baehring JM. Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity. Journal of Neuro-Oncology 2006; 76: 153-157.
14. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion weighted MRI. Neurology 1998; 51: 1369-1376.
15. Tajima Y, Isonishi K, Kashiwaba T, Tashiro K. Two similar cases of encephalopathy, possibly a reversible posterior leukoencephalopathy syndrome: serial findings of magnetic resonance imaging, SPECT and angiography. Internal Medicine 1999; 38: 54-58.
16. Eichler FS, Wang P, Wityk RJ, Beauchamp NJ Jr, Barker PB. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR. American Journal of Neuroradiology 2002; 23: 833-837.
17. Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR. American Journal of Neuroradiology 2002; 23: 1378-1386.
18. Shibutani M, Okeda R. Experimental study on subacute neurotoxicity of methotrexate in cats. Acta Neuropathologica 1989; 78: 291-300.
19. Laxmi SN, Takahashi S, Matsumoto K, et al. Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter. Radiation Medicine 1996; 14: 303-307.
20. Sakamaki H, Onozawa Y, Yano Y, et al. Disseminated necrotizing leukoencephalopathy following irradiation and MTX therapy for central nervous system infiltration of leukemia and lymphoma. Radiation Medicine 1993; 11: 146-153.
21. Nakashima A, Morimatsu M, Mukae T. Case of disseminated necrotizing leukoencephalopathy following intrathecal methotrexate in acute lymphocytic leukemia. Gan No Rinsho 1983; 29: 138-142.
22. Nakazato Y, Ishida Y, Morimatsu M. Disseminated necrotizing leukoencephalopathy. Acta Pathologica Japonica 1980; 30: 659-670.
23. Worthley SG, McNeil JD. Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis. Journal of Rheumatology 1995; 22: 335-337.
24. Dimitri Renard, Rene Westhovens, Erik Vandenbussche, Vandenberghe R. Reversible posterior leucoencephalopathy during oral treatment with methotrexate. Journal of Neurology 2004; 251: 226-228.